Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G207 + Radiation in Pediatric High-Grade Gliomas
NCT07649070Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of G207 in glioma, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2026; status: recruiting.
02
Drugs
G207
03
Conditions
glioma
Beyond the preview
Go deeper on NCT07649070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07649070.